Guardian Pharmacy Services GRDN Balance Sheet Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $64.89M+364% | $65.62M+1,308% | $36.49M-2.0% | $18.82M— | $14M— | ||
| $111.7M+14.7% | $101.61M+4.6% | $106.19M+16.8% | $94.13M+1,578% | $97.41M+921% | ||
| $47.16M+8.6% | $43.36M+6.9% | $47.86M+5.8% | $44.16M— | $43.43M+2,272% | ||
| $11.43M+2.0% | $11.04M+14.8% | $7.75M+12.5% | $13.36M— | $11.2M— | ||
| $235.18M+41.6% | $221.63M+45.8% | $198.28M+10.0% | $170.46M— | $166.04M— | ||
| $56.62M+10.0% | $55.52M+11.3% | $56.12M+16.6% | $54.43M— | $51.47M— | ||
| $34.27M+24.8% | $34.65M+19.2% | $32.21M+8.4% | $32.03M— | $27.45M— | ||
| $79.74M+15.1% | $79.74M+15.1% | $79.57M+16.3% | $76.16M— | $69.3M— | ||
| $17.48M+24.2% | $18.48M+23.9% | $18.92M+24.8% | $17.59M— | $14.08M— | ||
| $2.2M-58.3% | $2.2M-58.3% | $4.56M-23.6% | $5.27M— | $5.27M— | ||
| $1.45M+272% | $436K+13.8% | $387K+3.5% | $386K— | $388K— | ||
| $426.94M+27.8% | $412.66M+28.6% | $390.04M+12.1% | $356.33M— | $334M— | ||
| $108.55M+6.8% | $116.21M+13.5% | $121.68M+13.9% | $104.99M+2,430% | $101.67M+1,315% | ||
| $12.79M+22.1% | $15.05M+4.3% | $15.94M+14.3% | $17.29M— | $10.48M— | ||
| $7.22M+8.2% | $7.15M+4.6% | $6.72M-3.5% | $7.18M— | $6.67M— | ||
| —— | $3.88M+2.6% | —— | —— | —— | ||
| $160.54M+10.5% | $160.7M+11.5% | $161.95M+2.3% | $143.99M— | $145.3M— | ||
| $29.67M+36.1% | $29.99M+28.7% | $27.37M+14.8% | $26.52M— | $21.79M— | ||
| —— | $3.7M+8.4% | —— | —— | —— | ||
| $4.31M+16.7% | $4.04M+18.2% | $5.22M+58.0% | $6.16M— | $3.69M— | ||
| $194.52M+13.9% | $194.73M+14.0% | $194.54M-9.1% | $176.66M— | $170.78M— | ||
| $141.19M+9.1% | $139.35M+11.1% | $138.27M+13.0% | $133.9M— | $129.45M— | ||
| $79.64M+200% | $66.34M+287% | $45.42M+777% | $35.6M— | $26.57M— | ||
| $11.53M+61.8% | $12.17M+66.5% | $11.74M+85.5% | $10.11M— | $7.13M— | ||
| $232.42M+42.4% | $217.92M+45.3% | —— | —— | $163.22M— | ||
| $426.94M+27.8% | $412.66M+28.6% | $390.04M+12.1% | $356.33M— | $334M— | ||
| $11.43M+2.0% | $11.04M+14.8% | $7.75M+12.5% | $13.36M— | $11.2M— | ||
| $1.45M+272% | $436K+13.8% | $387K+3.5% | $386K— | $388K— | ||
| $34.27M+24.8% | $34.65M+19.2% | $32.21M+8.4% | $32.03M— | $27.45M— | ||
| $2.2M-58.3% | $2.2M-58.3% | $4.56M-23.6% | $5.27M— | $5.27M— | ||
| $17.48M+24.2% | $18.48M+23.9% | $18.92M+24.8% | $17.59M— | $14.08M— | ||
| $34.27M+24.8% | $34.65M+19.2% | $32.21M+8.4% | $32.03M— | $27.45M— | ||
| $1.45M+272% | $436K+13.8% | $387K+3.5% | $386K— | $388K— | ||
| $34.27M+24.8% | $34.65M+19.2% | $32.21M+8.4% | $32.03M— | $27.45M— | ||
| $1.45M+272% | $436K+13.8% | $387K+3.5% | $386K— | $388K— | ||
| $12.79M+22.1% | $15.05M+4.3% | $15.94M+14.3% | $17.29M— | $10.48M— | ||
| $12.79M+22.1% | $15.05M+4.3% | $15.94M+14.3% | $17.29M— | $10.48M— | ||
| $31.98M+20.8% | $22.3M+9.1% | $17.61M+16.7% | $14.52M— | $26.49M— | ||
| $36.89M+29.6% | $44.72M+19.8% | $34.08M-42.7% | $33.7M— | $28.46M— | ||
| $28.66M— | —— | —— | —— | —— | ||
| $28.66M— | —— | —— | —— | —— | ||
| —— | $3.88M+2.6% | —— | —— | —— | ||
| $11.53M+61.8% | $12.17M+66.5% | $11.74M+85.5% | $10.11M— | $7.13M— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Guardian Pharmacy Services's total assets?
- Guardian Pharmacy Services (GRDN) holds $426.9M in total assets, up 27.8% year over year.
- How much debt does Guardian Pharmacy Services have?
- Guardian Pharmacy Services carries $36.9M in total debt against $232.4M of shareholders' equity, a debt-to-equity ratio of 0.16.
- How much cash does Guardian Pharmacy Services have?
- Guardian Pharmacy Services holds $64.9M in cash and equivalents.
- Can Guardian Pharmacy Services cover its short-term obligations?
- Its current ratio is 1.46 — current assets exceed current liabilities.
- Where does Guardian Pharmacy Services's balance sheet data come from?
- Every line is extracted from Guardian Pharmacy Services's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
